Company Info

Failed to load

Systimmune, Inc.

Drug Discovery & Development

Overview

Failed to load

Contributions

Contributors

Contributions

1 Contributions1 / 1

Failed to load

FDA

SystImmune, Inc. Announces FDA Clearance of IND Application for BL-M11D1 in Relapsed/Refractory Acute Myeloid Leukemia

Systimmune, Inc.

PR-10-24-NI-42Oct 14, 2024

1 / 1

0 Contributors1 / 0

No authors found

1 / 0